RNP Therapeutics

We are developing combination therapy targeting tumor microenvironment (TME) by modulating non-coding RNA in combination with PD-1/PD-L1 checkpoint therapy

  • Stage Product In Development
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded June 2019
  • Employees 2
  • Incorporation Type Not Incorporated
  • Website rnptx.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free